BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Matsui O, Kadoya M, Yoshikawa J, Gabata T, Arai K, Demachi H, Miyayama S, Takashima T, Unoura M, Kogayashi K. Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 1993;188:79-83. [DOI: 10.1148/radiology.188.1.8390073] [Cited by in Crossref: 293] [Cited by in F6Publishing: 252] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Lubienski A. Hepatocellular carcinoma: interventional bridging to liver transplantation. Transplantation. 2005;80:S113-S119. [PMID: 16286887 DOI: 10.1097/01.tp.0000187109.69663.93] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
2 de Baere T, Arai Y, Lencioni R, Geschwind JF, Rilling W, Salem R, Matsui O, Soulen MC. Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion. Cardiovasc Intervent Radiol. 2016;39:334-343. [PMID: 26390875 DOI: 10.1007/s00270-015-1208-y] [Cited by in Crossref: 110] [Cited by in F6Publishing: 78] [Article Influence: 18.3] [Reference Citation Analysis]
3 Kim I, Kim DJ, Kim KA, Yoon SW, Lee JT. Feasibility of MDCT angiography for determination of tumor-feeding vessels in chemoembolization of hepatocellular carcinoma. J Comput Assist Tomogr 2014;38:742-6. [PMID: 24834885 DOI: 10.1097/RCT.0000000000000103] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
4 Luboldt W, Straub J, Seemann M, Helmberger T, Reiser M. Effective contrast use in CT angiography and dual-phase hepatic CT performed with a subsecond scanner. Invest Radiol 1999;34:751-60. [PMID: 10587871 DOI: 10.1097/00004424-199912000-00004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
5 Saccheri S, Lovaria A, Sangiovanni A, Nicolini A, De Fazio C, Ronchi G, Fasani P, Del Ninno E, Colombo M. Segmental Transcatheter Arterial Chemoembolization Treatment in Patients with Cirrhosis and Inoperable Hepatocellular Carcinomas. Journal of Vascular and Interventional Radiology 2002;13:995-9. [DOI: 10.1016/s1051-0443(07)61863-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
6 Meloni MF, Goldberg SN, Moser V, Piazza G, Livraghi T. Colonic perforation and abscess following radiofrequency ablation treatment of hepatoma. Eur J Ultrasound. 2002;15:73-76. [PMID: 12044857 DOI: 10.1016/s0929-8266(01)00171-9] [Cited by in Crossref: 59] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
7 Fujita T, Ito K, Tanabe M, Yamatogi S, Sasai H, Matsunaga N. Iodized oil accumulation in hypervascular hepatocellular carcinoma after transcatheter arterial chemoembolization: comparison of imaging findings with CT during hepatic arteriography. J Vasc Interv Radiol. 2008;19:333-341. [PMID: 18295691 DOI: 10.1016/j.jvir.2007.10.020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
8 Zurera L, Canis M, Marchal T, García-revillo J, Martos J, Benito A, Fraga E. Estudio histopatológico del efecto de la quimioembolización pretrasplante en el hepatocarcinoma. Radiología 2008;50:47-53. [DOI: 10.1016/s0033-8338(08)71928-3] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
9 Chen CW, Hsu LS, Weng JC, Weng HH, Ye YL, Hsu SL, Lin WM. Assessment of small hepatocellular carcinoma: perfusion quantification and time-concentration curve evaluation using color-coded and quantitative digital subtraction angiography. Medicine (Baltimore) 2018;97:e13392. [PMID: 30508937 DOI: 10.1097/MD.0000000000013392] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Woo S, Chung JW, Hur S, Joo SM, Kim HC, Jae HJ, Park JH. Liver abscess after transarterial chemoembolization in patients with bilioenteric anastomosis: frequency and risk factors. AJR Am J Roentgenol. 2013;200:1370-1377. [PMID: 23701078 DOI: 10.2214/ajr.12.9630] [Cited by in Crossref: 59] [Cited by in F6Publishing: 18] [Article Influence: 7.4] [Reference Citation Analysis]
11 Takayasu K, Arii S, Kudo M, Ichida T, Matsui O, Izumi N, Matsuyama Y, Sakamoto M, Nakashima O, Ku Y, Kokudo N, Makuuchi M. Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines. Journal of Hepatology 2012;56:886-92. [DOI: 10.1016/j.jhep.2011.10.021] [Cited by in Crossref: 112] [Cited by in F6Publishing: 96] [Article Influence: 12.4] [Reference Citation Analysis]
12 Choi BO, Jang HS, Kang KM, Lee SW, Kang YN, Chai GY, Choi IB. Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma. Jpn J Clin Oncol. 2006;36:154-158. [PMID: 16520355 DOI: 10.1093/jjco/hyi236] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 4.1] [Reference Citation Analysis]
13 Livraghi T. Guidelines for treatment of liver cancer. European Journal of Ultrasound 2001;13:167-76. [DOI: 10.1016/s0929-8266(01)00129-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
14 Yu SC, Hui JW, Hui EP, Mo F, Lee PS, Wong J, Lee KF, Lai PB, Yeo W. Embolization Efficacy and Treatment Effectiveness of Transarterial Therapy for Unresectable Hepatocellular Carcinoma: A Case-Controlled Comparison of Transarterial Ethanol Ablation with Lipiodol–Ethanol Mixture versus Transcatheter Arterial Chemoembolization. Journal of Vascular and Interventional Radiology 2009;20:352-9. [DOI: 10.1016/j.jvir.2008.12.407] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
15 Nakai M, Sato M, Kawai N, Minamiguchi H, Masuda M, Tanihata H, Takeuchi T, Terada M, Kishi K. Hepatocellular carcinoma: involvement of the internal mammary artery. Radiology. 2001;219:147-152. [PMID: 11274549 DOI: 10.1148/radiology.219.1.r01mr28147] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
16 Hieda M, Toyota N, Kakizawa H, Hirai N, Tachikake T, Matsuura N, Ishikawa M, Ito K. Evaluation of Hepatocellular Carcinoma Supplied by the Right Inferior Phrenic Artery at Initial Treatment: . Journal of Computer Assisted Tomography 2008;32:877-81. [DOI: 10.1097/rct.0b013e31815d9b1b] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
17 Liu D, Liu F, Xie X, Su L, Liu M, Kuang M, Huang G, Wang Y, Zhou H, Wang K, Lin M, Tian J. Accurate prediction of responses to transarterial chemoembolization for patients with hepatocellular carcinoma by using artificial intelligence in contrast-enhanced ultrasound. Eur Radiol. 2020;30:2365-2376. [PMID: 31900703 DOI: 10.1007/s00330-019-06553-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 27.0] [Reference Citation Analysis]
18 Olivo M, Valenza F, Buccellato A, Scala L, Virdone R, Sciarrino E, Di Piazza S, Marrone C, Orlando A, Fusco G. Transcatheter arterial chemoembolisation for hepatocellular carcinoma in cirrhosis: survival rate and prognostic factors. Dig Liver Dis. 2010;42:515-519. [PMID: 19914153 DOI: 10.1016/j.dld.2009.09.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
19 Sugimori K, Nozawa A, Morimoto M, Shirato K, Kokawa A, Saito T, Numata K, Tanaka K. Extension of radiofrequency ablation of the liver by transcatheter arterial embolization with iodized oil and gelatin sponge: results in a pig model. J Vasc Interv Radiol. 2005;16:849-856. [PMID: 15947049 DOI: 10.1097/01.rvi.0000157780.44868.78] [Cited by in Crossref: 33] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
20 Ishijima H, Koyama Y, Aoki J, Kawano T, Nakajima T, Ishizaka H, Endo K. Use of a Combined CT-Angiography System for Demonstration of Correlative Anatomy during Embolotherapy for Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 1999;10:811-5. [DOI: 10.1016/s1051-0443(99)70120-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
21 Minami Y, Kudo M. Imaging Modalities for Assessment of Treatment Response to Nonsurgical Hepatocellular Carcinoma Therapy: Contrast-Enhanced US, CT, and MRI. Liver Cancer 2015;4:106-14. [PMID: 26697413 DOI: 10.1159/000367733] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
22 Yu SCH, Leung TWT, Lau WY, Lee N, Hui EP, Yeo W, Lai PBS, Mok TSK. A Comparison of Three Transarterial Lipiodol-Based Formulations for Hepatocellular Carcinoma: In Vivo Biodistribution Study in Humans. Cardiovasc Intervent Radiol 2008;31:289-98. [DOI: 10.1007/s00270-007-9173-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
23 Hori M, Murakami T, Kim T, Takahashi S, Oi H, Tomoda K, Narumi Y, Nakamura H. Sensitivity of double-phase helical CT during arterial portography for detection of hypervascular hepatocellular carcinoma. J Comput Assist Tomogr. 1998;22:861-867. [PMID: 9843222 DOI: 10.1097/00004728-199811000-00004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
24 Golfieri R, Cappelli A, Cucchetti A, Piscaglia F, Carpenzano M, Peri E, Ravaioli M, D'Errico-Grigioni A, Pinna AD, Bolondi L. Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas. Hepatology. 2011;53:1580-1589. [PMID: 21351114 DOI: 10.1002/hep.24246] [Cited by in Crossref: 157] [Cited by in F6Publishing: 139] [Article Influence: 15.7] [Reference Citation Analysis]
25 Tsai YC, Shih JH, Hwang HE, Chiu NC, Lee RC, Tseng HS, Liu CA. Early prediction of 1-year tumor response of hepatocellular carcinoma with lipiodol deposition pattern through post-embolization cone-beam computed tomography during conventional transarterial chemoembolization. Eur Radiol 2021. [PMID: 33765160 DOI: 10.1007/s00330-021-07843-8] [Reference Citation Analysis]
26 Youk JH, Lee JM, Kim CS. Therapeutic response evaluation of malignant hepatic masses treated by interventional procedures with contrast-enhanced agent detection imaging. J Ultrasound Med 2003;22:911-20. [PMID: 14510262 DOI: 10.7863/jum.2003.22.9.911] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
27 Bannangkoon K, Hongsakul K, Tubtawee T, Piratvisuth T. Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization. Clin Mol Hepatol 2019;25:74-85. [PMID: 30813680 DOI: 10.3350/cmh.2018.0072] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
28 Miyayama S, Yamashiro M, Okuda M, Aburano H, Shigenari N, Morinaga K, Matsui O. Creation of a Cleft in an Angiography Catheter to Facilitate Catheterization of Branches of the Aorta Arising at an Acute Angle. Journal of Vascular and Interventional Radiology 2008;19:1769-71. [DOI: 10.1016/j.jvir.2008.08.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
29 Nouso K, Tanaka H, Uematsu S, Shiraga K, Okamoto R, Onishi H, Nakamura S, Kobayashi Y, Araki Y, Aoki N. Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances. J Gastroenterol Hepatol. 2008;23:437-444. [PMID: 17683496 DOI: 10.1111/j.1440-1746.2007.05054.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
30 Kobayashi N, Ishii M, Ueno Y, Kisara N, Chida N, Iwasaki T, Toyota T. Co-expression of Bcl-2 protein and vascular endothelial growth factor in hepatocellular carcinomas treated by chemoembolization. Liver. 1999;19:25-31. [PMID: 9928762 DOI: 10.1111/j.1478-3231.1999.tb00005.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 2.3] [Reference Citation Analysis]
31 Kitagawa K, Yamakado K, Nakatsuka A, Tanaka N, Fujii A, Takano K, Uraki J, Matsumura K, Takeda K. Selective Transcatheter Hepatic Arterial Chemoembolization for Hemobilia from Hepatocellular Carcinoma: Report of Three Cases. Journal of Vascular and Interventional Radiology 1999;10:1357-60. [DOI: 10.1016/s1051-0443(99)70243-5] [Cited by in Crossref: 14] [Article Influence: 0.6] [Reference Citation Analysis]
32 Hyodoh H, Hyodoh K, Takahashi K, Furuse M, Kawamoto C, Isoda N, Hozumi M, Ido K, Hirota N. Microwave coagulation therapy on hepatomas: CT and MR appearance after therapy. J Magn Reson Imaging 1998;8:451-8. [DOI: 10.1002/jmri.1880080228] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
33 Bannangkoon K, Hongsakul K, Tubtawee T, McNeil E, Sriplung H, Chongsuvivatwong V. Rate and Predictive Factors for Sustained Complete Response after Selective Transarterial Chemoembolization (TACE) in Patients with Hepatocellular Carcinoma. Asian Pac J Cancer Prev 2018;19:3545-50. [PMID: 30583681 DOI: 10.31557/APJCP.2018.19.12.3545] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
34 Lin D, Lin S, Liaw Y. Non-surgical treatment of hepatocellular carcinoma. J Gastroenterol Hepatol 1997;12:S319-28. [DOI: 10.1111/j.1440-1746.1997.tb00516.x] [Cited by in Crossref: 94] [Cited by in F6Publishing: 87] [Article Influence: 3.9] [Reference Citation Analysis]
35 Young S, Craig P, Golzarian J. Current trends in the treatment of hepatocellular carcinoma with transarterial embolization: a cross-sectional survey of techniques. Eur Radiol 2019;29:3287-95. [DOI: 10.1007/s00330-018-5782-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
36 Iwazawa J, Ohue S, Mitani T, Abe H, Hashimoto N, Hamuro M, Nakamura K. Identifying Feeding Arteries During TACE of Hepatic Tumors: Comparison of C-Arm CT and Digital Subtraction Angiography. American Journal of Roentgenology 2009;192:1057-63. [DOI: 10.2214/ajr.08.1285] [Cited by in Crossref: 80] [Cited by in F6Publishing: 24] [Article Influence: 6.7] [Reference Citation Analysis]
37 Song SY, Chung JW, Han JK, Lim HG, Koh YH, Park JH, Lee HS, Kim CY. Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome. J Vasc Interv Radiol. 2001;12:313-320. [PMID: 11287508 DOI: 10.1016/S1051-0443(07)61910-1] [Cited by in Crossref: 120] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
38 Lee JM, Kim IH, Kwak HS, Youk JH, Han YM, Kim CS. Detection of small hypervascular hepatocellular carcinomas in cirrhotic patients: comparison of superparamagnetic iron oxide-enhanced MR imaging with dual-phase spiral CT. Korean J Radiol 2003;4:1-8. [PMID: 12679628 DOI: 10.3348/kjr.2003.4.1.1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
39 Osuga K, Maeda N, Higashihara H, Hori S, Nakazawa T, Tanaka K, Nakamura M, Kishimoto K, Ono Y, Tomiyama N. Current status of embolic agents for liver tumor embolization. Int J Clin Oncol 2012;17:306-15. [PMID: 22806426 DOI: 10.1007/s10147-012-0445-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
40 Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, Matsuyama Y, Nakanuma Y, Kojiro M, Makuuchi M. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology. 2006;131:461-469. [PMID: 16890600 DOI: 10.1053/j.gastro.2006.05.021] [Cited by in Crossref: 524] [Cited by in F6Publishing: 460] [Article Influence: 34.9] [Reference Citation Analysis]
41 Miyayama S, Yamashiro M, Okuda M, Yoshie Y, Nakashima Y, Ikeno H, Orito N, Notsumata K, Watanabe H, Toya D, Tanaka N, Matsui O. Main bile duct stricture occurring after transcatheter arterial chemoembolization for hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2010;33:1168-1179. [PMID: 20058008 DOI: 10.1007/s00270-009-9781-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
42 Shimohira M, Ogino H, Kawai T, Kushita A, Watanabe M, Kawaguchi T, Kurono K, Shibamoto Y. Use of the triaxial microcatheter method in super-selective transcatheter arterial chemoembolisation for hepatocellular carcinoma. Br J Radiol 2011;84:184-7. [PMID: 21257838 DOI: 10.1259/bjr/26974088] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
43 Ahrar K, Gupta S. Hepatic artery embolization for hepatocellular carcinoma: technique, patient selection, and outcomes. Surg Oncol Clin N Am. 2003;12:105-126. [PMID: 12735133 DOI: 10.1016/s1055-3207(02)00089-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
44 Katsumori T, Fujita M, Takahashi T, Satoh O, Ichijima S, Nakamura T, Morishita H, Ohno K, Nakano Y, Maeda T. Effective segmental chemoembolization of advanced hepatocellular carcinoma with tumor thrombus in the portal vein. Cardiovasc Intervent Radiol. 1995;18:217-221. [PMID: 8581900 DOI: 10.1007/bf00239415] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
45 Li X, Hu G, Liu P. Segmental embolization by ethanol iodized oil emulsion for hepatocellular carcinoma. J Tongji Med Univ. 1999;19:135-140. [PMID: 12840858 DOI: 10.1007/bf02886895] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
46 Lee DH, Chung JW, Kim H, Jae HJ, Yoon CJ, Kang SG, Jeon UB, So YH, Yin YH, Park JH. Development of Diaphragmatic Weakness after Transcatheter Arterial Chemoembolization of the Right Inferior Phrenic Artery: Frequency and Determinant Factors. Journal of Vascular and Interventional Radiology 2009;20:484-9. [DOI: 10.1016/j.jvir.2008.11.023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
47 Valls C, Pamies J, Sancho C, Benasco C, Figueras J, Dominguez J, Jaurrieta E, Monta�a X. Computed tomography after Lipiodol chemoembolization in hepatocellular carcinoma. Eur Radiol 1994;4:238-42. [DOI: 10.1007/bf00606454] [Cited by in Crossref: 9] [Article Influence: 0.3] [Reference Citation Analysis]
48 Gu YK, Luo RG, Huang JH, Si Tu QJ, Li XX, Gao F. Transarterial embolization ablation of hepatocellular carcinoma with a lipiodol-ethanol mixture. World J Gastroenterol 2010;16:5766-72. [PMID: 21128329 DOI: 10.3748/wjg.v16.i45.5766] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
49 Chung JW, Park JH, Han JK, Choi BI, Kim TK, Han MC. Transcatheter oily chemoembolization of the inferior phrenic artery in hepatocellular carcinoma: the safety and potential therapeutic role. J Vasc Interv Radiol 1998;9:495-500. [PMID: 9618112 DOI: 10.1016/s1051-0443(98)70306-9] [Cited by in Crossref: 91] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
50 Yu SC, Hui EP, Wong J, Wong H, Mo F, Ho SS, Wong YY, Yeo W, Lai PB, Chan AT, Mok TS. Transarterial Ethanol Ablation of Hepatocellular Carcinoma with Lipiodol–Ethanol Mixture: Phase II Study. Journal of Vascular and Interventional Radiology 2008;19:95-103. [DOI: 10.1016/j.jvir.2007.08.038] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
51 Malagari K, Chatzimichael K, Alexopoulou E, Kelekis A, Hall B, Dourakis S, Delis S, Gouliamos A, Kelekis D. Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients. Cardiovasc Intervent Radiol. 2008;31:269-280. [PMID: 17999110 DOI: 10.1007/s00270-007-9226-z] [Cited by in Crossref: 162] [Cited by in F6Publishing: 137] [Article Influence: 11.6] [Reference Citation Analysis]
52 Sahara S, Tanihata H, Sato M, Kawai N, Takasaka I, Minamiguchi H, Nakai M, Sonomura T. Effects of hepatic artery chemoembolization using cisplatin-lipiodol suspension with gelatin sponge particles on swine liver. J Vasc Interv Radiol. 2009;20:1359-1364. [PMID: 19695901 DOI: 10.1016/j.jvir.2009.06.028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
53 Lee IJ, Seong J. The optimal selection of radiotherapy treatment for hepatocellular carcinoma. Gut Liver 2012;6:139-48. [PMID: 22570744 DOI: 10.5009/gnl.2012.6.2.139] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
54 Murakami R, Yoshimatsu S, Yamashita Y, Sagara K, Arakawa A, Takahashi M. Transcatheter Hepatic Subsegmental Arterial Chemoembolization Therapy Using Iodized Oil for Small Hepatocellular Carcinomas: Correlation between Lipiodol Accumulation Pattern and Local Recurrence. Acta Radiol 1994;35:576-80. [DOI: 10.1177/028418519403500613] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
55 Okada S. How to manage hepatic vein tumour thrombus in hepatocellular carcinoma. J Gastroenterol Hepatol. 2000;15:346-348. [PMID: 10824876 DOI: 10.1046/j.1440-1746.2000.02151.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
56 Matsui O, Kadoya M, Yoshikawa J, Gabata T, Takashima T, Demachi H. Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas: local therapeutic effect and 5-year survival rate. Cancer Chemother Pharmacol. 1994;33 Suppl:S84-S88. [PMID: 8137490 DOI: 10.1007/bf00686674] [Cited by in Crossref: 50] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
57 Blachar A, Federle MP, Sosna J. Liver Lesions With Hepatic Capsular Retraction. Seminars in Ultrasound, CT and MRI 2009;30:426-35. [DOI: 10.1053/j.sult.2009.06.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
58 Miyayama S, Yamashiro M, Hashimoto M, Hashimoto N, Ikuno M, Okumura K, Yoshida M, Matsui O. Identification of small hepatocellular carcinoma and tumor-feeding branches with cone-beam CT guidance technology during transcatheter arterial chemoembolization. J Vasc Interv Radiol 2013;24:501-8. [PMID: 23452552 DOI: 10.1016/j.jvir.2012.12.022] [Cited by in Crossref: 84] [Cited by in F6Publishing: 53] [Article Influence: 10.5] [Reference Citation Analysis]
59 Gunji T, Kawauchi N, Akahane M, Watanabe K, Kanamori H, Ohnishi S. Treatment of Unresectable Hepatocellular Carcinoma Less Than 2 Centimeters by Transcatheter Arterial Chemoembolization With Autologous Blood Clot: . Journal of Clinical Gastroenterology 2003;36:347-51. [DOI: 10.1097/00004836-200304000-00013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
60 Miyayama S, Yamashiro M, Shibata Y, Hashimoto M, Yoshida M, Tsuji K, Toshima F, Matsui O. Variations in feeding arteries of hepatocellular carcinoma located in the left hepatic lobe. Jpn J Radiol 2012;30:471-9. [DOI: 10.1007/s11604-012-0075-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
61 Murakami T, Takamura M, Kim T, Hori M, Federle MP, Onishi H, Tomoda K, Nakamura H. Double phase CT during hepatic arteriography for diagnosis of hepatocellular carcinoma. Eur J Radiol. 2005;54:246-252. [PMID: 15837405 DOI: 10.1016/j.ejrad.2004.05.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
62 Miyayama S, Yamashiro M, Hashimoto M, Hashimoto N, Ikuno M, Okumura K, Yoshida M, Matsui O. Comparison of local control in transcatheter arterial chemoembolization of hepatocellular carcinoma ≤ 6 cm with or without intraprocedural monitoring of the embolized area using cone-beam computed tomography. Cardiovasc Intervent Radiol. 2014;37:388-395. [PMID: 23775550 DOI: 10.1007/s00270-013-0667-2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
63 Murata S, Mine T, Sugihara F, Yasui D, Yamaguchi H, Ueda T, Onozawa S, Kumita S. Interventional treatment for unresectable hepatocellular carcinoma. World J Gastroenterol. 2014;20:13453-13465. [PMID: 25309076 DOI: 10.3748/wjg.v20.i37.13453] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
64 Miyayama S, Yamashiro M, Hattori Y, Orito N, Matsui K, Tsuji K, Yoshida M, Matsui O. Angiographic evaluation of feeding arteries of hepatocellular carcinoma in the caudate lobe of the liver. Cardiovasc Intervent Radiol 2011;34:1244-53. [PMID: 21085960 DOI: 10.1007/s00270-010-0036-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
65 Iwamoto S, Yamaguchi T, Hongo O, Iwamoto H, Sanefuji H. Excellent outcomes with angiographic subsegmentectomy in the treatment of typical hepatocellular carcinoma: A retrospective study of local recurrence and long-term survival rates in 120 patients with hepatocellular carcinoma. Cancer 2010;116:393-9. [DOI: 10.1002/cncr.24678] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
66 Huo T, Huang Y, Wu J, Lee P, Chang F, Lee S. Persistent retention of acetic acid is associated with complete tumour necrosis in patients with hepatocellular carcinoma undergoing percutaneous acetic acid injection. Scandinavian Journal of Gastroenterology 2009;39:168-73. [DOI: 10.1080/00365520310008269] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
67 Yang B, Li CL, Guo WH, Qin TQ, Jiao H, Fei ZJ, Zhou X, Duan LJ, Liao ZY. Intra-arterial ethanol embolization augments response to TACE for treatment of HCC with portal venous tumor thrombus. BMC Cancer 2018;18:101. [PMID: 29378532 DOI: 10.1186/s12885-018-3989-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
68 Yoshida K, Matsui O, Miyayama S, Ibukuro K, Yoneda N, Inoue D, Kozaka K, Minami T, Koda W, Gabata T. Isolated Arteries Originating from the Intrahepatic Arteries: Anatomy, Function, and Importance in Intervention.J Vasc Interv Radiol. 2018;29:531-537.e1. [PMID: 29477620 DOI: 10.1016/j.jvir.2017.12.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
69 Kishi Y, Hasegawa K, Sugawara Y, Kokudo N. Hepatocellular carcinoma: current management and future development-improved outcomes with surgical resection. Int J Hepatol. 2011;2011:728103. [PMID: 21994868 DOI: 10.4061/2011/728103] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
70 Miyayama S, Matsui O, Nishida H, Yamamori S, Minami T, Shinmura R, Kozaka K, Notsumata K, Toya D, Tanaka N. Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma fed by the cystic artery. J Vasc Interv Radiol. 2003;14:1155-1161. [PMID: 14514807 DOI: 10.1097/01.RVI.0000086534.86489.10] [Cited by in Crossref: 36] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
71 Malagari K, Alexopoulou E, Chatzimichail K, Hall B, Koskinas J, Ryan S, Gallardo E, Kelekis A, Gouliamos A, Kelekis D. Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead. Abdom Imaging. 2008;33:512-519. [PMID: 17938995 DOI: 10.1007/s00261-007-9334-x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 5.8] [Reference Citation Analysis]
72 Nishihara Y, Aishima S, Kuroda Y, Iguchi T, Taguchi K, Asayama Y, Taketomi A, Kinukawa N, Honda H, Tsuneyoshi M. Biliary phenotype of hepatocellular carcinoma after preoperative transcatheter arterial chemoembolization. Journal of Gastroenterology and Hepatology 2008;23:1860-8. [DOI: 10.1111/j.1440-1746.2008.05601.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
73 Takayasu K, Muramatsu Y, Maeda T, Iwata R, Furukawa H, Muramatsu Y, Moriyama N, Okusaka T, Okada S, Ueno H. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR Am J Roentgenol. 2001;176:681-688. [PMID: 11222205 DOI: 10.2214/ajr.176.3.1760681] [Cited by in Crossref: 121] [Cited by in F6Publishing: 108] [Article Influence: 6.1] [Reference Citation Analysis]
74 Yamashita T, Kaneko S. Treatment strategies for hepatocellular carcinoma in Japan. Hepatol Res. 2013;43:44-50. [PMID: 22583802 DOI: 10.1111/j.1872-034x.2012.01029.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
75 Lee KH, Sung KB, Lee DY, Park SJ, Kim KW, Yu JS. Transcatheter arterial chemoembolization for hepatocellular carcinoma: anatomic and hemodynamic considerations in the hepatic artery and portal vein. Radiographics. 2002;22:1077-1091. [PMID: 12235337 DOI: 10.1148/radiographics.22.5.g02se191077] [Cited by in Crossref: 43] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
76 Miyayama S, Matsui O, Taki K, Minami T, Ryu Y, Ito C, Nakamura K, Inoue D, Notsumata K, Toya D, Tanaka N, Mitsui T. Extrahepatic blood supply to hepatocellular carcinoma: angiographic demonstration and transcatheter arterial chemoembolization. Cardiovasc Intervent Radiol 2006;29:39-48. [PMID: 16328697 DOI: 10.1007/s00270-004-0287-y] [Cited by in Crossref: 102] [Cited by in F6Publishing: 67] [Article Influence: 6.8] [Reference Citation Analysis]
77 Jihye C, Jinsil S. Application of Radiotherapeutic Strategies in the BCLC-Defined Stages of Hepatocellular Carcinoma. Liver Cancer 2012;1:216-25. [PMID: 24159586 DOI: 10.1159/000343836] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
78 Miyayama S, Matsui O, Yamashiro M, Ryu Y, Takata H, Takeda T, Aburano H, Shigenari N. Iodized oil accumulation in the hypovascular tumor portion of early-stage hepatocellular carcinoma after ultraselective transcatheter arterial chemoembolization. Hepatol Int. 2007;1:451-459. [PMID: 19669342 DOI: 10.1007/s12072-007-9030-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
79 Ishimaru H, Nakashima K, Sakugawa T, Sakamoto A, Matsuoka Y, Ashizawa K, Uetani M. Local recurrence after chemoembolization of hepatocellular carcinoma: uptake of gadoxetic acid as a new prognostic factor. AJR Am J Roentgenol 2014;202:744-51. [PMID: 24660701 DOI: 10.2214/AJR.13.10848] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
80 Yamasaki T, Saeki I, Harima Y, Zaitsu J, Maeda M, Tanimoto H, Iwamoto T, Hidaka I, Urata Y, Ishikawa T, Takami T, Yamaguchi Y, Uchida K, Terai S, Sakaida I. Effect of transcatheter arterial infusion chemotherapy using iodized oil and degradable starch microspheres for hepatocellular carcinoma. J Gastroenterol 2012;47:715-22. [DOI: 10.1007/s00535-012-0537-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
81 Kakeda S, Korogi Y, Ohnari N, Moriya J, Oda N, Nishino K, Miyamoto W. Usefulness of cone-beam volume CT with flat panel detectors in conjunction with catheter angiography for transcatheter arterial embolization. J Vasc Interv Radiol. 2007;18:1508-1516. [PMID: 18057285 DOI: 10.1016/j.jvir.2007.08.003] [Cited by in Crossref: 93] [Cited by in F6Publishing: 70] [Article Influence: 7.2] [Reference Citation Analysis]
82 Shimohira M, Ogino H, Kawai T, Sakurai K, Nakagawa M, Shibamoto Y. Clinical usefulness of the triaxial system in super-selective transcatheter arterial chemoembolization for hepatocellular carcinoma. Acta Radiol. 2012;53:857-861. [PMID: 22850577 DOI: 10.1258/ar.2012.120044] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
83 Hyodoh H, Furuse M, Kawamoto C, Isoda N, Ido K, Saito K. Microwave coagulation therapy: Ex vivo comparison of MR imaging and histopathology. J Magn Reson Imaging 2000;11:168-73. [DOI: 10.1002/(sici)1522-2586(200002)11:2<168::aid-jmri14>3.0.co;2-w] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
84 Miyayama S, Matsui O, Yamashiro M, Ryu Y, Kaito K, Ozaki K, Takeda T, Yoneda N, Notsumata K, Toya D, Tanaka N, Mitsui T. Ultraselective Transcatheter Arterial Chemoembolization with a 2-F Tip Microcatheter for Small Hepatocellular Carcinomas: Relationship Between Local Tumor Recurrence and Visualization of the Portal Vein with Iodized Oil. Journal of Vascular and Interventional Radiology 2007;18:365-76. [DOI: 10.1016/j.jvir.2006.12.004] [Cited by in Crossref: 162] [Cited by in F6Publishing: 128] [Article Influence: 11.6] [Reference Citation Analysis]
85 Bartolozzi C, Cioni D, Donati F, Granai G, Lencioni R. Imaging Evaluation of Tumor Response. In: Bartolozzi C, Lencioni R, editors. Liver Malignancies. Berlin: Springer Berlin Heidelberg; 1999. pp. 467-87. [DOI: 10.1007/978-3-642-58641-5_30] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
86 Wang Q, Xia D, Bai W, Wang E, Sun J, Huang M, Mu W, Yin G, Li H, Zhao H, Li J, Zhang C, Zhu X, Wu J, Gong W, Li Z, Lin Z, Pan X, Shi H, Shao G, Liu J, Yang S, Zheng Y, Xu J, Song J, Wang W, Wang Z, Zhang Y, Ding R, Zhang H, Yu H, Zheng L, Gu W, You N, Wang G, Zhang S, Feng L, Liu L, Zhang P, Li X, Chen J, Xu T, Zhou W, Zeng H, Huang W, Jiang W, Zhang W, Shao W, Li L, Niu J, Yuan J, Lv Y, Li K, Yin Z, Xia J, Fan D, Han G;  China HCC-TACE Study Group. Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study. J Hepatol. 2019;70:893-903. [PMID: 30660709 DOI: 10.1016/j.jhep.2019.01.013] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 25.0] [Reference Citation Analysis]
87 Yamakado K, Nakatsuka A, Tanaka N, Matsumura K, Takase K, Takeda K. Long-term Follow-up Arterial Chemoembolization Combined with Transportal Ethanol Injection Used to Treat Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 1999;10:641-7. [DOI: 10.1016/s1051-0443(99)70095-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
88 Takayasu K. Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: recent progression and perspective. Oncology. 2013;84 Suppl 1:28-33. [PMID: 23428855 DOI: 10.1159/000345886] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
89 Maeda N, Osuga K, Mikami K, Higashihara H, Onishi H, Nakaya Y, Tatsumi M, Hori M, Kim T, Tomoda K, Nakamura H. Angiographic evaluation of hepatic arterial damage after transarterial chemoembolization for hepatocellular carcinoma. Radiat Med 2008;26:206-12. [DOI: 10.1007/s11604-007-0216-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
90 Takayasu K, Arii S, Matsuo N, Yoshikawa M, Ryu M, Takasaki K, Sato M, Yamanaka N, Shimamura Y, Ohto M. Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. AJR Am J Roentgenol. 2000;175:699-704. [PMID: 10954453 DOI: 10.2214/ajr.175.3.1750699] [Cited by in Crossref: 162] [Cited by in F6Publishing: 139] [Article Influence: 7.7] [Reference Citation Analysis]
91 Hayashi K, Kumada T, Nakano S, Takeda I, Sugiyama K, Kiriyama S, Sone Y, Miyata A, Shimizu H, Satomura S. Usefulness of measurement of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma. Am J Gastroenterol 1999;94:3028-33. [PMID: 10520864 DOI: 10.1111/j.1572-0241.1999.01378.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 44] [Article Influence: 1.5] [Reference Citation Analysis]
92 Shiraga K, Sakaguchi K, Senoh T, Ohta T, Ogawa S, Sawayama T, Mouri H, Fujiwara A, Tsuji T. Modulation of doxorubicin sensitivity by cyclosporine A in hepatocellular carcinoma cells and their doxorubicin-resistant sublines. J Gastroenterol Hepatol 2001;16:460-6. [PMID: 11354286 DOI: 10.1046/j.1440-1746.2001.02457.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
93 Inaba Y, Arai Y, Sone M, Aramaki T, Osuga K, Tanaka H, Kanemasa K. Clinical trial for development of a steerable microcatheter. Minimally Invasive Therapy & Allied Technologies 2019;28:1-5. [DOI: 10.1080/13645706.2018.1467458] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
94 Kim HC, Chung JW, Jae HJ, Yoon JH, Lee JH, Kim YJ, Lee HS, Yoon CJ, Park JH. Caudate lobe hepatocellular carcinoma treated with selective chemoembolization. Radiology 2010;257:278-87. [PMID: 20697120 DOI: 10.1148/radiol.10100105] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
95 Sasaki A, Iwashita Y, Shibata K, Matsumoto T, Ohta M, Kitano S. Improved long-term survival after liver resection for hepatocellular carcinoma in the modern era: retrospective study from HCV-endemic areas. World J Surg. 2006;30:1567-1578. [PMID: 16855807 DOI: 10.1007/s00268-005-0249-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
96 Matsui O, Miyayama S, Sanada J, Kobayashi S, Khoda W, Minami T, Kozaka K, Gabata T. Interventional oncology: new options for interstitial treatments and intravascular approaches: superselective TACE using iodized oil for HCC: rationale, technique and outcome. J Hepatobiliary Pancreat Sci. 2010;17:407-409. [PMID: 19885639 DOI: 10.1007/s00534-009-0234-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
97 Saeki I, Yamasaki T, Maeda M, Hisanaga T, Iwamoto T, Matsumoto T, Hidaka I, Ishikawa T, Takami T, Sakaida I. Evaluation of the "assessment for continuous treatment with hepatic arterial infusion chemotherapy" scoring system in patients with advanced hepatocellular carcinoma. Hepatol Res 2018;48:E87-97. [PMID: 28656680 DOI: 10.1111/hepr.12932] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
98 Tanaka T, Ikeda M, Okusaka T, Ueno H, Morizane C, Ogura T, Hagihara A, Iwasa S. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization. Cancer Chemother Pharmacol 2008;61:683-8. [DOI: 10.1007/s00280-007-0523-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
99 Ando E, Tanaka M, Yamashita F, Kuromatsu R, Takada A, Fukumori K, Yano Y, Sumie S, Okuda K, Kumashiro R. Diagnostic clues for recurrent hepatocellular carcinoma: comparison of tumour markers and imaging studies. Eur J Gastroenterol Hepatol. 2003;15:641-648. [PMID: 12840676 DOI: 10.1097/00042737-200306000-00011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
100 Miyayama S, Yamashiro M, Nagai K, Tohyama J, Kawamura K, Yoshida M, Sakuragawa N. Evaluation of tumor recurrence after superselective conventional transcatheter arterial chemoembolization for hepatocellular carcinoma: Comparison of computed tomography and gadoxetate disodium-enhanced magnetic resonance imaging: CT vs Gd-EOB-MRI for recurrent HCC after cTACE. Hepatol Res 2016;46:890-8. [DOI: 10.1111/hepr.12632] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
101 Cao W, Li JH, Feng DY, Wan Y, Liu YF, Yang QF, Cheng JW, Zhao SY, Zhang HX. Effect of transarterial pulsed perfusion with heated saline on tumor vascular permeability in a rabbit VX2 liver tumor model. Eur J Radiol 2012;81:e209-16. [PMID: 21345630 DOI: 10.1016/j.ejrad.2011.01.108] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
102 Ji SK, Cho YK, Ahn YS, Kim MY, Park YO, Kim JK, Kim WT. Multivariate analysis of the predictors of survival for patients with hepatocellular carcinoma undergoing transarterial chemoembolization: focusing on superselective chemoembolization. Korean J Radiol. 2008;9:534-540. [PMID: 19039270 DOI: 10.3348/kjr.2008.9.6.534] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
103 Minami Y, Yagyu Y, Murakami T, Kudo M. Tracking Navigation Imaging of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Using Three-Dimensional Cone-Beam CT Angiography. Liver Cancer. 2014;3:53-61. [PMID: 24804177 DOI: 10.1159/000343858] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 4.1] [Reference Citation Analysis]
104 Ueda K, Kitagawa K, Kadoya M, Matsui O, Takashima T, Yamahana T. Detection of hypervascular hepatocellular carcinoma by using spiral volumetric CT: Comparison of US and MR imaging. Abdom Imaging 1995;20:547-53. [DOI: 10.1007/bf01256709] [Cited by in Crossref: 22] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
105 Satake M, Uchida H, Arai Y, Anai H, Sakaguchi H, Nagata T, Yamane T, Kichikawa K, Osaki Y, Okazaki M, Higashihara H, Nakamura H, Osuga K, Nakao N, Hirota S. Transcatheter arterial chemoembolization (TACE) with lipiodol to treat hepatocellular carcinoma: survey results from the TACE study group of Japan. Cardiovasc Intervent Radiol 2008;31:756-61. [PMID: 18389187 DOI: 10.1007/s00270-007-9255-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
106 Zhang Z, Liu Q, He J, Yang J, Yang G, Wu M. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma. Cancer 2000;89:2606-12. [DOI: 10.1002/1097-0142(20001215)89:12<2606::aid-cncr13>3.0.co;2-t] [Cited by in Crossref: 65] [Article Influence: 3.1] [Reference Citation Analysis]
107 Miraglia R, Pietrosi G, Maruzzelli L, Petridis I, Caruso S, Marrone G, Mamone G, Vizzini G, Luca A, Gridelli B. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma. World J Gastroenterol 2007;13:2952-5. [PMID: 17589945 DOI: 10.3748/wjg.v13.i21.2952] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
108 Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, Shiina S, Cheng AL, Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chawla YK, Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF, Sarin SK. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010;4:439-74. [PMID: 20827404 DOI: 10.1007/s12072-010-9165-7] [Reference Citation Analysis]
109 Fu X, Luo RG, Qiu W, Ouyang L, Fan GQ, Liang QR, Tang Q. Sustained release of arsenic trioxide benefits interventional therapy on rabbit VX2 liver tumor. Nanomedicine 2020;24:102118. [PMID: 31678180 DOI: 10.1016/j.nano.2019.102118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
110 Mikami E, Kanno N, Ueno Y, Shimosegawa T. Retrospective evaluation of tumor-mass-reduction therapy for the prognosis of recurrent hepatocellular carcinoma. Hepatol Int 2007;1:460-8. [PMID: 19669343 DOI: 10.1007/s12072-007-9021-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
111 Huo TI, Huang YH, Wu JC, Chiang JH, Lee PC, Chang FY, Lee SD. Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective study. Ann Oncol 2003;14:1648-53. [PMID: 14581273 DOI: 10.1093/annonc/mdg460] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
112 Miyayama S, Yamashiro M, Okuda M, Yoshie Y, Sugimori N, Igarashi S, Nakashima Y, Notsumata K, Toya D, Tanaka N. Chemoembolization for the treatment of large hepatocellular carcinoma. J Vasc Interv Radiol. 2010;21:1226-1234. [PMID: 20598571 DOI: 10.1016/j.jvir.2010.04.015] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
113 Miyayama S, Matsui O, Akakura Y, Yamamoto T, Nishida H, Yoneda K, Kawai K, Nishijima H. Hepatocellular Carcinoma with Blood Supply from Omental Branches: Treatment with Transcatheter Arterial Embolization. Journal of Vascular and Interventional Radiology 2001;12:1285-90. [DOI: 10.1016/s1051-0443(07)61553-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
114 Takaki S, Sakaguchi H, Anai H, Tanaka T, Yamamoto K, Morimoto K, Nishiofuku H, Inoue M, Sueyoshi S, Nagata T. Long-term outcome of transcatheter subsegmental and segmental arterial chemoemobolization using lipiodol for hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2012;35:544-554. [PMID: 21739345 DOI: 10.1007/s00270-011-0224-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
115 Tu J, Jia Z, Ying X, Zhang D, Li S, Tian F, Jiang G. The incidence and outcome of major complication following conventional TAE/TACE for hepatocellular carcinoma. Medicine (Baltimore) 2016;95:e5606. [PMID: 27930585 DOI: 10.1097/MD.0000000000005606] [Cited by in Crossref: 30] [Cited by in F6Publishing: 7] [Article Influence: 7.5] [Reference Citation Analysis]
116 Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, Tateishi R, Han KH, Chawla YK, Shiina S, Jafri W, Payawal DA, Ohki T, Ogasawara S, Chen PJ, Lesmana CRA, Lesmana LA, Gani RA, Obi S, Dokmeci AK, Sarin SK. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11:317-370. [PMID: 28620797 DOI: 10.1007/s12072-017-9799-9] [Cited by in Crossref: 661] [Cited by in F6Publishing: 569] [Article Influence: 165.3] [Reference Citation Analysis]
117 Sakamoto T, Saito Y, Kobayashi M, Yamada T, Takekuma Y, Nakai M, Ogawa K, Iseki K, Sugawara M. Effect of palonosetron and dexamethasone administration on the prevention of gastrointestinal symptoms in hepatic arterial chemoembolization with epirubicin. Support Care Cancer 2020;28:3251-7. [PMID: 31732854 DOI: 10.1007/s00520-019-05178-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
118 Cao W, Wan Y, Liang ZH, Duan YY, Liu X, Wang ZM, Liu YY, Zhu J, Liu XT, Zhang HX. Heated lipiodol as an embolization agent for transhepatic arterial embolization in VX2 rabbit liver cancer model. Eur J Radiol. 2010;73:412-419. [PMID: 19091502 DOI: 10.1016/j.ejrad.2008.11.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
119 Ono Y, Yoshimasu T, Ashikaga R, Inoue M, Shindou H, Fuji K, Araki Y, Nishimura Y. Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma. Am J Clin Oncol. 2000;23:564-568. [PMID: 11202797 DOI: 10.1097/00000421-200012000-00006] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 2.7] [Reference Citation Analysis]
120 Ishikawa T, Abe S, Inoue R, Sugano T, Watanabe Y, Iwanaga A, Seki K, Honma T, Nemoto T, Takeda K. Predictive factor of local recurrence after balloon-occluded TACE with miriplatin (MPT) in hepatocellular carcinoma. PLoS One. 2014;9:e103009. [PMID: 25047920 DOI: 10.1371/journal.pone.0103009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
121 Colombo M. Hepatocellular carcinoma in patients with HCV. Best Practice & Research Clinical Gastroenterology 2000;14:327-39. [DOI: 10.1053/bega.1999.0079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
122 Nomura H, Miyake K, Hirakata R, Migita S, Okamoto O, Shiraishi G. Rebamipide prevents occurrence of gastric lesions following transcatheter arterial embolization in the hepatic artery. J Gastroenterol Hepatol. 1999;14:495-499. [PMID: 10355516 DOI: 10.1046/j.1440-1746.1999.01889.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
123 Miyayama S, Yamashiro M, Shibata Y, Hashimoto M, Yoshida M, Tsuji K, Toshima F, Matsui O. Comparison of local control effects of superselective transcatheter arterial chemoembolization using epirubicin plus mitomycin C and miriplatin for hepatocellular carcinoma. Jpn J Radiol. 2012;30:263-270. [PMID: 22223074 DOI: 10.1007/s11604-011-0043-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
124 Sacco R, Bertini M, Petruzzi P, Bertoni M, Bargellini I, Bresci G, Federici G, Gambardella L, Metrangolo S, Parisi G, Romano A, Scaramuzzino A, Tumino E, Silvestri A, Altomare E, Vignali C, Capria A. Clinical impact of selective transarterial chemoembolization on hepatocellular carcinoma: a cohort study. World J Gastroenterol 2009;15:1843-8. [PMID: 19370781 DOI: 10.3748/wjg.15.1843] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
125 Kaizu T, Karasawa K, Tanaka Y, Matuda T, Kurosaki H, Tanaka S, Kumazaki T. Radiotherapy for osseous metastases from hepatocellular carcinoma: a retrospective study of 57 patients. Am J Gastroenterol. 1998;93:2167-2171. [PMID: 9820391 DOI: 10.1111/j.1572-0241.1998.00614.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 49] [Article Influence: 2.7] [Reference Citation Analysis]
126 Feng G, Kramann B, Zheng C, Zhou R. [Comparative study on the long-term effect of permanent embolization of hepatic artery with Bletilla striata in patients with primary liver cancer]. J Tongji Med Univ 1996;16:111-6. [PMID: 9324524 DOI: 10.1007/BF02887970] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
127 Baek MY, Yoo JJ, Jeong SW, Jang JY, Kim YK, Jeong SO, Lee SH, Kim SG, Cha SW, Kim YS, Cho YD, Kim HS, Kim BS, Kim YJ, Park SY. Clinical outcomes of patients with a single hepatocellular carcinoma less than 5 cm treated with transarterial chemoembolization. Korean J Intern Med 2019;34:1223-32. [PMID: 30360019 DOI: 10.3904/kjim.2018.058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
128 Liao XF, Yi JL, Li XR, Deng W, Yang ZF, Tian G. Angiogenesis in rabbit hepatic tumor after transcatheter arterial embolization. World J Gastroenterol. 2004;10:1885-1889. [PMID: 15222029 DOI: 10.3748/wjg.v10.i13.1885] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
129 Lin OS, Keeffe EB, Sanders GD, Owens DK. Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C. Aliment Pharmacol Ther. 2004;19:1159-1172. [PMID: 15153169 DOI: 10.1111/j.1365-2036.2004.01963.x] [Cited by in Crossref: 121] [Cited by in F6Publishing: 90] [Article Influence: 7.1] [Reference Citation Analysis]
130 Miyayama S, Matsui O, Zen Y, Yamashiro M, Hattori Y, Orito N, Matsui K, Tsuji K, Yoshida M, Sudo Y. Portal blood supply to locally progressed hepatocellular carcinoma after transcatheter arterial chemoembolization: Observation on CT during arterial portography. Hepatol Res. 2011;41:853-866. [PMID: 21699636 DOI: 10.1111/j.1872-034x.2011.00836.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
131 Katsumori T, Kasahara T. The size of gelatin sponge particles: differences with preparation method. Cardiovasc Intervent Radiol 2006;29:1077-83. [PMID: 16967213 DOI: 10.1007/s00270-006-0059-y] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
132 Yu SC, Hui JW, Hui EP, Chan SL, Lee KF, Mo F, Wong J, Ma B, Lai P, Mok T. Unresectable hepatocellular carcinoma: randomized controlled trial of transarterial ethanol ablation versus transcatheter arterial chemoembolization. Radiology. 2014;270:607-620. [PMID: 24126369 DOI: 10.1148/radiol.13130498] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
133 Ravaioli M, Grazi GL, Ercolani G, Fiorentino M, Cescon M, Golfieri R, Trevisani F, Grigioni WF, Bolondi L, Pinna AD. Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. Transplantation. 2004;78:1780-1786. [PMID: 15614151 DOI: 10.1097/01.tp.0000145892.97114.ee] [Cited by in Crossref: 92] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
134 Ikushima I, Higashi S, Ishii A, Seguchi K, Iryo Y, Yamashita Y. Ultraselective transcatheter infusion of epirubicin in water-in-oil-in-water emulsion for small hepatocellular carcinoma. Br J Radiol 2012;85:e584-9. [PMID: 22422389 DOI: 10.1259/bjr/16376960] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
135 Guang C, Kawai N, Sato M, Takasaka I, Minamiguchi H, Sahara S, Nakata K, Sonomura T, Shirai S, Mori I, Yang R. Effect of interval between transcatheter hepatic arterial embolization and radiofrequency ablation on ablated lesion size in a swine model. Jpn J Radiol 2011;29:649-55. [PMID: 21956371 DOI: 10.1007/s11604-011-0611-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
136 Ohnishi K, Yoshioka H, Ito S, Fujiwara K. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 1998;27:67-72. [DOI: 10.1002/hep.510270112] [Cited by in Crossref: 166] [Cited by in F6Publishing: 141] [Article Influence: 7.2] [Reference Citation Analysis]
137 Saeki I, Terai S, Fujisawa K, Takami T, Yamamoto N, Matsumoto T, Hirose Y, Murata Y, Yamasaki T, Sakaida I. Bortezomib induces tumor-specific cell death and growth inhibition in hepatocellular carcinoma and improves liver fibrosis. J Gastroenterol. 2013;48:738-750. [PMID: 23011081 DOI: 10.1007/s00535-012-0675-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
138 Bartolozzi C, Lencioni R, Caramella D, Palla A, Bassi AM, Di Candio G. Small Hepatocellular Carcinoma: Detection with US, CT, MR Imaging, DSA, and Lipiodol-CT. Acta Radiol 1996;37:69-74. [DOI: 10.1177/02841851960371p114] [Cited by in Crossref: 32] [Cited by in F6Publishing: 13] [Article Influence: 6.4] [Reference Citation Analysis]
139 Bouvier A, Ozenne V, Aubé C, Boursier J, Vullierme MP, Thouveny F, Farges O, Vilgrain V. Transarterial chemoembolisation: effect of selectivity on tolerance, tumour response and survival. Eur Radiol 2011;21:1719-26. [PMID: 21479978 DOI: 10.1007/s00330-011-2118-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
140 Geschwind JF, Kaushik S, Ramsey DE, Choti MA, Fishman EK, Kobeiter H. Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors. J Vasc Interv Radiol. 2002;13:1163-1166. [PMID: 12427817 DOI: 10.1016/s1051-0443(07)61959-9] [Cited by in Crossref: 89] [Cited by in F6Publishing: 20] [Article Influence: 4.9] [Reference Citation Analysis]
141 Terayama N, Miyayama S, Tatsu H, Yamamoto T, Toya D, Tanaka N, Mitsui T, Miura S, Fujisawa M, Kifune K, Matsui O, Takashima T. Subsegmental transcatheter arterial embolization for hepatocellular carcinoma in the caudate lobe. J Vasc Interv Radiol 1998;9:501-8. [PMID: 9618113 DOI: 10.1016/s1051-0443(98)70307-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
142 Kakeda S, Korogi Y, Hatakeyama Y, Ohnari N, Oda N, Nishino K, Miyamoto W. The usefulness of three-dimensional angiography with a flat panel detector of direct conversion type in a transcatheter arterial chemoembolization procedure for hepatocellular carcinoma: initial experience. Cardiovasc Intervent Radiol. 2008;31:281-288. [PMID: 18026792 DOI: 10.1007/s00270-007-9114-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
143 Park SI, Lee DY, Won JY, Lee JT. Extrahepatic collateral supply of hepatocellular carcinoma by the intercostal arteries. J Vasc Interv Radiol. 2003;14:461-468. [PMID: 12682202 DOI: 10.1097/01.rvi.0000064856.87207.1e] [Cited by in Crossref: 49] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
144 Chen R, Gan Y, Ge N, Chen Y, Wang Y, Zhang B, Wang Y, Ye S, Ren Z. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study. J Vasc Interv Radiol 2016;27:1829-36. [PMID: 27553917 DOI: 10.1016/j.jvir.2016.06.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
145 Hamada A, Yamakado K, Nakatsuka A, Takaki H, Akeboshi M, Takeda K. Hepatic Arterial Infusion Chemotherapy with Use of an Implanted Port System in Patients with Advanced Hepatocellular Carcinoma: Prognostic Factors. Journal of Vascular and Interventional Radiology 2004;15:835-41. [DOI: 10.1097/01.rvi.0000128815.35555.0e] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
146 Toyoda H, Kumada T, Sone Y. Impact of a unified CT angiography system on outcome of patients with hepatocellular carcinoma. AJR Am J Roentgenol. 2009;192:766-774. [PMID: 19234276 DOI: 10.2214/ajr.08.1368] [Cited by in Crossref: 23] [Cited by in F6Publishing: 5] [Article Influence: 1.9] [Reference Citation Analysis]
147 Park KH, Kwon SH, Lee YS, Jeong SW, Jang JY, Lee SH, Kim SG, Cha SW, Kim YS, Cho YD, Kim HS, Kim BS, Kim YJ. Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma. Clin Mol Hepatol 2015;21:158-64. [PMID: 26157753 DOI: 10.3350/cmh.2015.21.2.158] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
148 Woo HY, Yoo SY, Heo J. Peretinoin, an Acyclic Retinoid, for the Secondary Prevention of Hepatocellular Carcinoma. Molecules 2021;26:E295. [PMID: 33435572 DOI: 10.3390/molecules26020295] [Reference Citation Analysis]
149 Choi JM, Park KM, Kim SH, Hwang DW, Chon SH, Lee JH, Lee SY, Lee YJ. Effect of necrosis modulator necrox-7 on hepatic ischemia-reperfusion injury in beagle dogs. Transplant Proc 2010;42:3414-21. [PMID: 21094788 DOI: 10.1016/j.transproceed.2010.08.050] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
150 Ilyas A, Hashim Z, Naeem N, Haneef K, Zarina S. The effect of alendronate on proteome of hepatocellular carcinoma cell lines. Int J Proteomics. 2014;2014:532953. [PMID: 24653834 DOI: 10.1155/2014/532953] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
151 Murata S, Mine T, Ueda T, Nakazawa K, Onozawa S, Yasui D, Kumita S. Transcatheter arterial chemoembolization based on hepatic hemodynamics for hepatocellular carcinoma. ScientificWorldJournal 2013;2013:479805. [PMID: 23606815 DOI: 10.1155/2013/479805] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
152 Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, Shiina S, Cheng AL, Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chawla YK, Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF, Sarin SK. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int. 2010;4:439-474. [PMID: 20827404 DOI: 10.1007/s12072-010-9165-7] [Cited by in Crossref: 684] [Cited by in F6Publishing: 651] [Article Influence: 62.2] [Reference Citation Analysis]
153 Ueda T, Murata S, Mine T, Onozawa S, Onda M, Naito Z, Amano Y, Kumita S. Comparison of epirubicin-iodized oil suspension and emulsion for transcatheter arterial chemoembolization in VX2 tumor. ScientificWorldJournal 2012;2012:961986. [PMID: 22489208 DOI: 10.1100/2012/961986] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
154 Takami T, Yamasaki T, Saeki I, Matsumoto T, Suehiro Y, Sakaida I. Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver function. World J Gastroenterol 2016;22:7252-63. [PMID: 27621572 DOI: 10.3748/wjg.v22.i32.7252] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
155 Yamasaki T, Kurokawa F, Shirahashi H, Kusano N, Hironaka K, Okita K. Percutaneous radiofrequency ablation therapy with combined angiography and computed tomography assistance for patients with hepatocellular carcinoma. Cancer 2001;91:1342-8. [DOI: 10.1002/1097-0142(20010401)91:7<1342::aid-cncr1137>3.0.co;2-0] [Cited by in Crossref: 54] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
156 Komada Y, Murata S, Tajima H, Kumita S, Kanazawa H, Tajiri T. Haemodynamic changes in the liver under balloon occlusion of a portal vein branch: evaluation with single-level dynamic computed tomography during hepatic arteriography. Clin Radiol. 2007;62:579-586. [PMID: 17467396 DOI: 10.1016/j.crad.2007.01.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
157 Tanaka K, Nakamura S, Numata K, Kondo M, Morita K, Kitamura T, Saito S, Kiba T, Okazaki H, Sekihara H. The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis. Cancer 1998;82:78-85. [PMID: 9428482 DOI: 10.1002/(sici)1097-0142(19980101)82:1<78::aid-cncr9>3.0.co;2-g] [Cited by in Crossref: 54] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
158 Liu WC, Lim JH, Park CK, Kim MJ, Kim SH, Lee SJ, Lee WJ, Lim HK. Poor sensitivity of sonography in detection of hepatocellular carcinoma in advanced liver cirrhosis: accuracy of pretransplantation sonography in 118 patients. Eur Radiol 2003;13:1693-8. [PMID: 12835987 DOI: 10.1007/s00330-002-1814-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
159 Kitao A, Zen Y, Matsui O, Gabata T, Nakanuma Y. Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography--radiologic-pathologic correlation. Radiology. 2009;252:605-614. [PMID: 19703890 DOI: 10.1148/radiol.2522081414] [Cited by in Crossref: 130] [Cited by in F6Publishing: 104] [Article Influence: 10.8] [Reference Citation Analysis]
160 Aishima S, Iguchi T, Nishihara Y, Fujita N, Taguchi K, Taketomi A, Maehara Y, Tsuneyoshi M. Decreased intratumoral arteries reflect portal tract destruction and aggressive characteristics in intrahepatic cholangiocarcinoma. Histopathology 2009;54:452-61. [DOI: 10.1111/j.1365-2559.2009.03240.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
161 Fujita K, Iwama H, Miyoshi H, Tani J, Oura K, Tadokoro T, Sakamoto T, Nomura T, Morishita A, Yoneyama H, Masaki T. Diabetes mellitus and metformin in hepatocellular carcinoma. World J Gastroenterol 2016;22:6100-13. [PMID: 27468203 DOI: 10.3748/wjg.v22.i27.6100] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
162 Miyayama S, Matsui O, Taki K, Minami T, Ito C, Shinmura R, Takamatsu S, Kobayashi M, Notsumata K. Combined Use of an Occlusion Balloon Catheter and a Microcatheter for Embolization of the Unselectable Right Inferior Phrenic Artery Supplying Hepatocellular Carcinoma. CVIR 2004;27:677-80. [DOI: 10.1007/s00270-004-0216-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
163 Teratani T, Ishikawa T, Shiratori Y, Shiina S, Yoshida H, Imamura M, Obi S, Sato S, Hamamura K, Omata M. Hepatocellular carcinoma in elderly patients: beneficial therapeutic efficacy using percutaneous ethanol injection therapy. Cancer. 2002;95:816-823. [PMID: 12209726 DOI: 10.1002/cncr.10735] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
164 Miyayama S, Yamashiro M, Okuda M, Yoshie Y, Sugimori N, Igarashi S, Nakashima Y, Matsui O. Usefulness of cone-beam computed tomography during ultraselective transcatheter arterial chemoembolization for small hepatocellular carcinomas that cannot be demonstrated on angiography. Cardiovasc Intervent Radiol. 2009;32:255-264. [PMID: 19067043 DOI: 10.1007/s00270-008-9468-4] [Cited by in Crossref: 87] [Cited by in F6Publishing: 75] [Article Influence: 6.7] [Reference Citation Analysis]
165 Yang DM, Kim HS, Cho SW, Kim HS. Pictorial review: various causes of hepatic capsular retraction: CT and MR findings. Br J Radiol 2002;75:994-1002. [PMID: 12515710 DOI: 10.1259/bjr.75.900.750994] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
166 Nakayama H, Sugahara S, Tokita M, Fukuda K, Mizumoto M, Abei M, Shoda J, Sakurai H, Tsuboi K, Tokuuye K. Proton beam therapy for hepatocellular carcinoma: the University of Tsukuba experience. Cancer. 2009;115:5499-5506. [PMID: 19645024 DOI: 10.1002/cncr.24619] [Cited by in Crossref: 89] [Cited by in F6Publishing: 65] [Article Influence: 8.1] [Reference Citation Analysis]
167 Pacella CM, Bizzarri G, Magnolfi F, Cecconi P, Caspani B, Anelli V, Bianchini A, Valle D, Pacella S, Manenti G, Rossi Z. Laser thermal ablation in the treatment of small hepatocellular carcinoma: results in 74 patients. Radiology. 2001;221:712-720. [PMID: 11719667 DOI: 10.1148/radiol.2213001501] [Cited by in Crossref: 105] [Cited by in F6Publishing: 83] [Article Influence: 5.3] [Reference Citation Analysis]
168 Tan GX, Miranda R, Sutherland T. Causes of hepatic capsular retraction: a pictorial essay. Insights Imaging 2016;7:831-40. [PMID: 27686493 DOI: 10.1007/s13244-016-0520-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
169 Takaki-Hamabe S, Yamasaki T, Saeki I, Harima Y, Okita K, Terai S, Sakaida I. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: Is the addition of subcutaneous interferon-alpha-2b beneficial? Hepatol Res. 2009;39:223-230. [PMID: 19054152 DOI: 10.1111/j.1872-034x.2008.00458.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
170 Miraglia R, Pietrosi G, Maruzzelli L, Petridis I, Caruso S, Marrone G, Mamone G, Vizzini G, Luca A, Gridelli B. Predictive factors of tumor response to trans-catheter treatment in cirrhotic patients with hepatocellular carcinoma: a multivariate analysis of pre-treatment findings. World J Gastroenterol 2007;13:6022-6. [PMID: 18023093 DOI: 10.3748/wjg.v13.45.6022] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
171 Nakano MM, Yamamoto A, Nishida N, Hamuro M, Hamamoto S, Jogo A, Sohgawa E, Kageyama K, Minami T, Miki Y. Risk factors for local recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE). Jpn J Radiol 2019;37:543-8. [DOI: 10.1007/s11604-019-00840-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
172 Oran I, Memis A. The watershed between right and left hepatic artery territories: findings on CT scans after transcatheter oily chemoembolization of hepatic tumors. A preliminary report. Surg Radiol Anat 1998;20:355-60. [PMID: 9894317 DOI: 10.1007/BF01630621] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
173 Eriguchi T, Takeda A, Sanuki N, Oku Y, Aoki Y, Shigematsu N, Kunieda E. Acceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary system. Int J Radiat Oncol Biol Phys. 2013;85:1006-1011. [PMID: 23102838 DOI: 10.1016/j.ijrobp.2012.09.012] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
174 Goshima S, Kanematsu M, Kondo H, Yokoyama R, Tsuge Y, Shiratori Y, Onozuka M, Moriyama N. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator? J Magn Reson Imaging. 2008;27:834-839. [PMID: 18383261 DOI: 10.1002/jmri.21316] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
175 Morimoto M, Shirato K, Sugimori K, Kokawa A, Tomita N, Saito T, Imada T, Tanaka N, Nozawa A, Numata K. Contrast-enhanced harmonic gray-scale sonographic-histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. AJR Am J Roentgenol. 2003;181:65-69. [PMID: 12818831 DOI: 10.2214/ajr.181.1.1810065] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 1.8] [Reference Citation Analysis]
176 Golfieri R, Bezzi M, Verset G, Fucilli F, Mosconi C, Cappelli A, Paccapelo A, Lucatelli P, Magand N, Rode A, De Baere T. Retrospective European Multicentric Evaluation of Selective Transarterial Chemoembolisation with and without Balloon-Occlusion in Patients with Hepatocellular Carcinoma: A Propensity Score Matched Analysis. Cardiovasc Intervent Radiol 2021;44:1048-59. [PMID: 33709273 DOI: 10.1007/s00270-021-02805-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
177 Takaki H, Yamakado K, Nakatsuka A, Fuke H, Murata K, Shiraki K, Takeda K. Radiofrequency Ablation Combined with Chemoembolization for the Treatment of Hepatocellular Carcinomas 5 cm or Smaller: Risk Factors for Local Tumor Progression. Journal of Vascular and Interventional Radiology 2007;18:856-61. [DOI: 10.1016/j.jvir.2007.04.022] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 3.5] [Reference Citation Analysis]
178 Miyayama S, Matsui O. Superselective Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma: Rationale, Technique, and Outcome. J Vasc Interv Radiol. 2016;27:1269-1278. [PMID: 27345337 DOI: 10.1016/j.jvir.2016.04.014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 5.4] [Reference Citation Analysis]
179 Yamagami T, Yoshimatsu R, Nishimori M, Ogi K, Tamura T, Iwasaki S, Yamanishi T. Use of proximal side-hole micro-balloon catheter in transcatheter hepatic arterial chemoembolization. Minimally Invasive Therapy & Allied Technologies 2017;26:372-6. [DOI: 10.1080/13645706.2017.1322614] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
180 Kudo M, Han KH, Ye SL, Zhou J, Huang YH, Lin SM, Wang CK, Ikeda M, Chan SL, Choo SP, Miyayama S, Cheng AL. A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements. Liver Cancer 2020;9:245-60. [PMID: 32647629 DOI: 10.1159/000507370] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 25.0] [Reference Citation Analysis]
181 Lee DH, Lee JM, Klotz E, Kim SJ, Kim KW, Han JK, Choi BI. Detection of recurrent hepatocellular carcinoma in cirrhotic liver after transcatheter arterial chemoembolization: value of quantitative color mapping of the arterial enhancement fraction of the liver. Korean J Radiol 2013;14:51-60. [PMID: 23323031 DOI: 10.3348/kjr.2013.14.1.51] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
182 Shimada K, Sakamoto Y, Esaki M, Kosuge T, Morizane C, Ikeda M, Ueno H, Okusaka T, Arai Y, Takayasu K. Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol. 2007;14:2337-2347. [PMID: 17503155 DOI: 10.1245/s10434-007-9415-7] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
183 Suh SH, Won JY, Lee DY, Lee JT, Lee K. Chemoembolization of the Left Inferior Phrenic Artery in Patients with Hepatocellular Carcinoma: Radiographic Findings and Clinical Outcome. Journal of Vascular and Interventional Radiology 2005;16:1741-5. [DOI: 10.1097/01.rvi.0000182172.00168.1b] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
184 Mizukoshi E, Nakamoto Y, Arai K, Yamashita T, Mukaida N, Matsushima K, Matsui O, Kaneko S. Enhancement of tumor-specific T-cell responses by transcatheter arterial embolization with dendritic cell infusion for hepatocellular carcinoma. Int J Cancer. 2010;126:2164-2174. [PMID: 19739081 DOI: 10.1002/ijc.24882] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
185 Baum RA, Baum S. Interventional radiology: a half century of innovation. Radiology 2014;273:S75-91. [PMID: 25340439 DOI: 10.1148/radiol.14140534] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
186 Itai Y. Lipiodol-CT for hepatocellular carcinoma. Abdom Imaging. 1997;22:259-260. [PMID: 9107645 DOI: 10.1007/s002619900184] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
187 Park JW, Park KW, Cho SH, Park HS, Lee WJ, Lee DH, Kim CM. Risk of hepatitis B exacerbation is low after transcatheter arterial chemoembolization therapy for patients with HBV-related hepatocellular carcinoma: report of a prospective study. Am J Gastroenterol. 2005;100:2194-2200. [PMID: 16181368 DOI: 10.1111/j.1572-0241.2005.00232.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
188 Choi J, Shim JH, Shin YM, Kim KM, Lim YS, Lee HC. Clinical significance of the best response during repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma. J Hepatol. 2014;60:1212-1218. [PMID: 24486088 DOI: 10.1016/j.jhep.2014.01.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
189 Hieda M, Toyota N, Kakizawa H, Ishikawa M, Horiguchi J, Ito K. The Anterior Branch of the Left Inferior Phrenic Artery Arising from the Right Inferior Phrenic Artery: An Angiographic and CT Study. Cardiovasc Intervent Radiol 2009;32:250-4. [DOI: 10.1007/s00270-008-9434-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
190 Sakamoto I, Iwanaga S, Nagaoki K, Matsuoka Y, Ashizawa K, Uetani M, Fukuda T, Okimoto T, Okudaira S, Omagari K. Intrahepatic biloma formation (bile duct necrosis) after transcatheter arterial chemoembolization. AJR Am J Roentgenol. 2003;181:79-87. [PMID: 12818833 DOI: 10.2214/ajr.181.1.1810079] [Cited by in Crossref: 63] [Cited by in F6Publishing: 51] [Article Influence: 3.5] [Reference Citation Analysis]
191 Irie T, Kuramochi M, Kamoshida T, Takahashi N. Selective balloon-occluded transarterial chemoembolization for patients with one or two hepatocellular carcinoma nodules: Retrospective comparison with conventional super-selective TACE. Hepatol Res. 2016;46:209-214. [PMID: 26224032 DOI: 10.1111/hepr.12564] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
192 Miyayama S, Yamashiro M, Ikuno M, Okumura K, Yoshida M. Ultraselective transcatheter arterial chemoembolization for small hepatocellular carcinoma guided by automated tumor-feeders detection software: technical success and short-term tumor response. Abdom Imaging 2014;39:645-56. [DOI: 10.1007/s00261-014-0094-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
193 Miyayama S, Yamakado K, Anai H, Abo D, Minami T, Takaki H, Kodama T, Yamanaka T, Nishiofuku H, Morimoto K, Soyama T, Hasegawa Y, Nakamura K, Yamanishi T, Sato M, Nakajima Y. Guidelines on the use of gelatin sponge particles in embolotherapy. Jpn J Radiol 2014;32:242-50. [PMID: 24510242 DOI: 10.1007/s11604-014-0292-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 4.1] [Reference Citation Analysis]
194 Okada Y, Ina H, Kubota K, Himeno Y, Wakita T, Ohashi I, Gomi N, Yoshida T, Mae S, Irie T. Computed tomography-guided transarterial chemoembolization as the initial therapy for hepatocellular carcinoma: experience of 75 cases in a single institute. Dig Dis Sci 2003;48:587-93. [PMID: 12757174 DOI: 10.1023/a:1022557220624] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
195 Yang MJ, An SY, Moon EJ, Lee MS, Hwang JA, Cheong JY, Won JH, Kim JK, Wang HJ, Cho SW. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm]. Korean J Hepatol. 2009;15:474-485. [PMID: 20037266 DOI: 10.3350/kjhep.2009.15.4.474] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
196 Tsurusaki M, Murakami T. Surgical and Locoregional Therapy of HCC: TACE. Liver Cancer 2015;4:165-75. [PMID: 26675172 DOI: 10.1159/000367739] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 8.2] [Reference Citation Analysis]
197 Yamasaki T, Hamabe S, Saeki I, Harima Y, Yamaguchi Y, Uchida K, Terai S, Sakaida I. A novel transcatheter arterial infusion chemotherapy using iodized oil and degradable starch microspheres for hepatocellular carcinoma: a prospective randomized trial. J Gastroenterol 2011;46:359-66. [DOI: 10.1007/s00535-010-0306-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
198 Liang HL, Yang CF, Pan HB, Lai KH, Cheng JS, Lo GH, Chen CK, Lai PH. Small hepatocellular carcinoma: safety and efficacy of single high-dose percutaneous acetic acid injection for treatment. Radiology 2000;214:769-74. [PMID: 10715044 DOI: 10.1148/radiology.214.3.r00mr06769] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
199 Lanza E, Donadon M, Poretti D, Pedicini V, Tramarin M, Roncalli M, Rhee H, Park YN, Torzilli G. Transarterial Therapies for Hepatocellular Carcinoma. Liver Cancer 2016;6:27-33. [PMID: 27995085 DOI: 10.1159/000449347] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 5.4] [Reference Citation Analysis]
200 Takayasu K. Transarterial chemoembolization for hepatocellular carcinoma over three decades: current progress and perspective. Jpn J Clin Oncol. 2012;42:247-255. [PMID: 22407946 DOI: 10.1093/jjco/hys020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
201 Saeki I, Yamasaki T, Tanabe N, Iwamoto T, Matsumoto T, Urata Y, Hidaka I, Ishikawa T, Takami T, Yamamoto N. A new therapeutic assessment score for advanced hepatocellular carcinoma patients receiving hepatic arterial infusion chemotherapy. PLoS One. 2015;10:e0126649. [PMID: 25992784 DOI: 10.1371/journal.pone.0126649] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
202 Yan K, Chen MH, Yang W, Wang YB, Gao W, Hao CY, Xing BC, Huang XF. Radiofrequency ablation of hepatocellular carcinoma: long-term outcome and prognostic factors. Eur J Radiol. 2008;67:336-347. [PMID: 17765421 DOI: 10.1016/j.ejrad.2007.07.007] [Cited by in Crossref: 75] [Cited by in F6Publishing: 65] [Article Influence: 5.4] [Reference Citation Analysis]
203 Horikawa M, Miyayama S, Irie T, Kaji T, Arai Y. Development of Conventional Transarterial Chemoembolization for Hepatocellular Carcinomas in Japan: Historical, Strategic, and Technical Review. American Journal of Roentgenology 2015;205:764-73. [DOI: 10.2214/ajr.15.14825] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
204 Numata K, Tanaka K, Kiba T, Matsumoto S, Iwase S, Hara K, Kirikoshi H, Morita K, Saito S, Sekihara H. Nonresectable Hepatocellular Carcinoma: Improved Percutaneous Ethanol Injection Therapy Guided by CO 2 -Enhanced Sonography. American Journal of Roentgenology 2001;177:789-98. [DOI: 10.2214/ajr.177.4.1770789] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
205 Shin SW, Do YS, Choo SW, Lieu WC, Cho SK, Park KB, Yoo BC, Kang EH, Choo I. Diaphragmatic Weakness after Transcatheter Arterial Chemoembolization of Inferior Phrenic Artery for Treatment of Hepatocellular Carcinoma. Radiology 2006;241:581-8. [DOI: 10.1148/radiol.2412051209] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
206 Wagnetz U, Jaskolka J, Yang P, Jhaveri KS. Acute Ischemic Cholecystitis After Transarterial Chemoembolization of Hepatocellular Carcinoma: Incidence and Clinical Outcome. Journal of Computer Assisted Tomography 2010;34:348-53. [DOI: 10.1097/rct.0b013e3181caaea3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
207 Minami Y, Kudo M. Therapeutic response assessment of transcatheter arterial chemoembolization for hepatocellular carcinoma: ultrasonography, CT and MR imaging. Oncology. 2013;84 Suppl 1:58-63. [PMID: 23428860 DOI: 10.1159/000345891] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
208 Yamagata M, Masaki T, Okudaira T, Imai Y, Shiina S, Shiratori Y, Omata M. Small hyperechoic nodules in chronic liver diseases include hepatocellular carcinomas with low cyclin D1 and Ki-67 expression. Hepatology 1999;29:1722-9. [PMID: 10347114 DOI: 10.1002/hep.510290606] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
209 Hayashi K, Ina H, Tezuka M, Okada Y, Irie T. Local therapeutic results of computed tomography-guided transcatheter arterial chemoembolization for hepatocellular carcinoma: results of 265 tumors in 79 patients. Cardiovasc Intervent Radiol. 2007;30:1144-1155. [PMID: 17909884 DOI: 10.1007/s00270-007-9169-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
210 Tanaka H, Iijima H, Nouso K, Aoki N, Iwai T, Takashima T, Sakai Y, Aizawa N, Iwata K, Ikeda N, Iwata Y, Enomoto H, Saito M, Imanishi H, Nishiguchi S. Cost-effectiveness analysis on the surveillance for hepatocellular carcinoma in liver cirrhosis patients using contrast-enhanced ultrasonography: Cost-effectiveness of CEUS surveillance for HCC. Hepatology Research 2012;42:376-84. [DOI: 10.1111/j.1872-034x.2011.00936.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
211 Chen R, Gan Y, Ge N, Chen Y, Ma H, Wang Y, Zhang B, Wang Y, Ye S, Luo J, Ren Z. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching: TACE versus RFA for early HCC. Journal of Gastroenterology and Hepatology 2016;31:442-9. [DOI: 10.1111/jgh.13077] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
212 Kumada T, Nakano S, Takeda I, Kiriyama S, Sone Y, Hayashi K, Katoh H, Endoh T, Sassa T, Satomura S. Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis. Journal of Hepatology 1999;30:125-30. [DOI: 10.1016/s0168-8278(99)80016-6] [Cited by in Crossref: 102] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
213 Wintersperger BJ, Nikolaou K, Becker CR. Multidetector-row CT angiography of the aorta and visceral arteries. Semin Ultrasound CT MR 2004;25:25-40. [PMID: 15035530 DOI: 10.1053/j.sult.2003.10.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
214 Staudacher C, Chiappa A, Biella F, Audisio RA, Bertani E, Zbar AP. Validation of the Modified Tnm-Izumi Classification for Hepatocellular Carcinoma. Tumori 2000;86:8-11. [DOI: 10.1177/030089160008600102] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
215 Liu Y, Yang R. Preoperative Combined with Postoperative Chemoembolization Can Improve Survival in Patients with Hepatocellular Carcinoma: A Single-center Study. Journal of Vascular and Interventional Radiology 2009;20:472-83. [DOI: 10.1016/j.jvir.2009.01.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
216 Miyayama S, Yamashiro M, Shibata Y, Hashimoto M, Yoshida M, Tsuji K, Toshima F, Matsui O. Origins of Feeding Arteries of Hepatocellular Carcinoma Located Near the Umbilical Fissure of the Left Hepatic Lobe: Angiographic Evaluation. Cardiovasc Intervent Radiol 2012;35:1380-7. [DOI: 10.1007/s00270-011-0328-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
217 Makuuchi M, Kokudo N, Arii S, Futagawa S, Kaneko S, Kawasaki S, Matsuyama Y, Okazaki M, Okita K, Omata M. Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res. 2008;38:37-51. [PMID: 18039202 DOI: 10.1111/j.1872-034x.2007.00216.x] [Cited by in Crossref: 211] [Cited by in F6Publishing: 78] [Article Influence: 21.1] [Reference Citation Analysis]
218 Tanikake M, Shimizu T, Narabayashi I, Matsuki M, Masuda K, Yamamoto K, Uesugi Y, Yoshikawa S. Three-dimensional CT angiography of the hepatic artery: use of multi-detector row helical CT and a contrast agent. Radiology. 2003;227:883-889. [PMID: 12773687 DOI: 10.1148/radiol.2273011964] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
219 Roche A. Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma. In: Bartolozzi C, Lencioni R, editors. Liver Malignancies. Berlin: Springer Berlin Heidelberg; 1999. pp. 255-74. [DOI: 10.1007/978-3-642-58641-5_17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
220 Louis C, Dewas S, Mirabel X, Lacornerie T, Adenis A, Bonodeau F, Lartigau E. Stereotactic radiotherapy of hepatocellular carcinoma: preliminary results. Technol Cancer Res Treat. 2010;9:479-487. [PMID: 20815419 DOI: 10.1177/153303461000900506] [Cited by in Crossref: 86] [Cited by in F6Publishing: 73] [Article Influence: 7.8] [Reference Citation Analysis]
221 Korean Liver Cancer Association., National Cancer Center. 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Gut Liver 2019;13:227-99. [PMID: 31060120 DOI: 10.5009/gnl19024] [Cited by in Crossref: 90] [Cited by in F6Publishing: 75] [Article Influence: 90.0] [Reference Citation Analysis]
222 Iwazawa J, Ohue S, Hashimoto N, Abe H, Hamuro M, Mitani T. Detection of hepatocellular carcinoma: comparison of angiographic C-arm CT and MDCT. AJR Am J Roentgenol. 2010;195:882-887. [PMID: 20858813 DOI: 10.2214/ajr.10.4417] [Cited by in Crossref: 35] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
223 Imai N, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Hirooka Y, Goto H. Transarterial chemoembolization for hepatocellular carcinoma: A review of techniques. World J Hepatol. 2014;6:844-850. [PMID: 25544871 DOI: 10.4254/wjh.v6.i12.844] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
224 Shimada K, Sakamoto Y, Esaki M, Kosuge T. Role of a hepatectomy for the treatment of large hepatocellular carcinomas measuring 10 cm or larger in diameter. Langenbecks Arch Surg 2008;393:521-6. [DOI: 10.1007/s00423-007-0264-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
225 Farinati F, Gianni S, Marin G, Fagiuoli S, Rinaldi M, Naccarato R. Does the choice of treatment influence survival of patients with small hepatocellular carcinoma in compensated cirrhosis?: . European Journal of Gastroenterology & Hepatology 2001;13:1217-24. [DOI: 10.1097/00042737-200110000-00015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
226 Shiraishi R, Yamasaki T, Saeki I, Okita K, Yamaguchi Y, Uchida K, Terai S, Sakaida I. Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma. Am J Clin Oncol. 2008;31:311-316. [PMID: 18845987 DOI: 10.1097/coc.0b013e31815e4539] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
227 Sung YM, Choi D, Lim HK, Lee WJ, Kim SH, Kim MJ, Paik SW, Yoo BC, Koh KC, Lee JH, Choi MS. Long-term results of percutaneous ethanol injection for the treatment of hepatocellular carcinoma in Korea. Korean J Radiol 2006;7:187-92. [PMID: 16969048 DOI: 10.3348/kjr.2006.7.3.187] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
228 Lee SH, Hahn ST, Yoo J, Kim J. Hemostatic effect of glue-lipiodol mixture plugged in the needle tract after renal biopsies in a high-risk, anticoagulated rabbit model. Invest Radiol 2000;35:684-8. [PMID: 11110305 DOI: 10.1097/00004424-200011000-00006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
229 Matsui O. Current status of hepatocellular carcinoma treatment in Japan: transarterial chemoembolization. Clin Drug Investig 2012;32 Suppl 2:3-13. [PMID: 22873623 DOI: 10.1007/BF03265492] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
230 Gerard B, Bleiberg H. Treatment of hepatocarcinoma. Curr Oncol Rep 2004;6:184-91. [PMID: 15066229 DOI: 10.1007/s11912-004-0048-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
231 Miyayama S, Mitsui T, Zen Y, Sudo Y, Yamashiro M, Okuda M, Yoshie Y, Sanada T, Notsumata K, Tanaka N. Histopathological findings after ultraselective transcatheter arterial chemoembolization for hepatocellular carcinoma. Hepatol Res. 2009;39:374-381. [PMID: 19054146 DOI: 10.1111/j.1872-034x.2008.00465.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
232 Ueki T, Sakaguchi S, Miyajima Y, Hatono N, Tohara K, Nakabayashi S, Yao T, Kokawa H, Hirano M, Okumura M. Usefulness of tumor pressure as a prognostic factor in cases of hepatocellular carcinoma where the diameter of the tumor is 3 cm or less. Cancer 2002;95:596-604. [PMID: 12209753 DOI: 10.1002/cncr.10690] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
233 Jeon UB, Lee JW, Choo KS, Kim CW, Kim S, Lee TH, Jeong YJ, Kang DH. Iodized oil uptake assessment with cone-beam CT in chemoembolization of small hepatocellular carcinomas. World J Gastroenterol 2009;15:5833-7. [PMID: 19998505 DOI: 10.3748/wjg.15.5833] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
234 Soyer P. Capsular retraction of the liver in malignant tumor of the biliary tract MRI findings. Clin Imaging. 1994;18:255-257. [PMID: 8000952 DOI: 10.1016/0899-7071(94)90003-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
235 Akamatsu M, Yoshida H, Obi S, Sato S, Koike Y, Fujishima T, Tateishi R, Imamura M, Hamamura K, Teratani T. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial. Liver Int. 2004;24:625-629. [PMID: 15566514 DOI: 10.1111/j.1478-3231.2004.0963.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
236 Yu SCH, Chan CTP. Transarterial Ethanol Ablation of Cirrhotic Liver With Lipiodol-Ethanol Mixture: Safety and Efficacy Study in Rats. Investigative Radiology 2006;41:609-17. [DOI: 10.1097/01.rli.0000223884.05289.c3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
237 Hsu KF, Chu CH, Chan DC, Yu JC, Shih ML, Hsieh HF, Hsieh TY, Yu CY, Hsieh CB. Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function. Eur J Radiol. 2012;81:466-471. [PMID: 21376495 DOI: 10.1016/j.ejrad.2010.12.058] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
238 Yamada R, Kishi K, Sato M, Sonomura T, Nishida N, Tanaka K, Shioyama Y, Terada M, Kimura M. Transcatheter arterial chemoembolization (TACE) in the treatment of unresectable liver cancer. World J Surg. 1995;19:795-800. [PMID: 8553668 DOI: 10.1007/bf00299773] [Cited by in Crossref: 39] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
239 Katagiri S, Yamamoto M. Multidisciplinary treatments for hepatocellular carcinoma with major portal vein tumor thrombus. Surg Today. 2014;44:219-226. [PMID: 23591833 DOI: 10.1007/s00595-013-0585-6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
240 Choi J, Lee D, Shim JH, Kim KM, Lim YS, Lee YS, Lee HC. Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma.PLoS One. 2020;15:e0229696. [PMID: 32130270 DOI: 10.1371/journal.pone.0229696] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
241 Malagari K. Drug-eluting particles in the treatment of HCC: chemoembolization with doxorubicin-loaded DC Bead. Expert Rev Anticancer Ther. 2008;8:1643-1650. [PMID: 18925855 DOI: 10.1586/14737140.8.10.1643] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
242 Shima T, Mizuno M, Otsuji H, Mizuno C, Obata H, Park H, Nakajo S, Okanoue T. Evaluation of transcatheter arterial embolization therapy on hepatocellular carcinomas using contrast-enhanced harmonic power Doppler sonography: comparison with CT, power Doppler sonography, and dynamic MRI. J Med Ultrason (2001) 2005;32:107-13. [PMID: 27277266 DOI: 10.1007/s10396-005-0045-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
243 Tajima T, Nishie A, Asayama Y, Ishigami K, Ushijima Y, Kakihara D, Honda H. Safety Margins of Hepatocellular Carcinoma Demonstrated by 3-Dimensional Fused Images of Computed Tomographic Hepatic Arteriography/Unenhanced Computed Tomography: Prognostic Significance in Patients Who Underwent Transcatheter Arterial Chemoembolization. Journal of Computer Assisted Tomography 2010;34:712-9. [DOI: 10.1097/rct.0b013e3181e1d241] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
244 Ito K, Kusunoki H, Okamoto E, Ozawa M, Ishikawa A, Matsuura M, Nakajima N. Intra-arterial alcoholization of advanced hepatocellular carcinoma. Cancer Chemother Pharmacol. 1994;33 Suppl:S42-S47. [PMID: 8137484 DOI: 10.1007/bf00686667] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
245 Takayasu K. Superselective transarterial chemoembolization for hepatocellular carcinoma: recent progression and perspective. Oncology 2011;81 Suppl 1:105-10. [PMID: 22212943 DOI: 10.1159/000333269] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
246 Mochizuki T, Tsuda T, Sugawara Y, Tanaka H, Kikuchi T, Miyagawa M, Shimizu K, Murase K, Iuchi H, Onji M, Ikezoe J. Tc-99m PMT Hepatobiliary Scintigraphy in the Differential Diagnosis of Extrahepatic Metastases and Hepatocellular Carcinoma: . Clinical Nuclear Medicine 2000;25:991-5. [DOI: 10.1097/00003072-200012000-00006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
247 Soulen MC. Multimodality Image-Guided Therapy for Liver Tumors. Journal of Vascular and Interventional Radiology 2003;14:P211-7. [DOI: 10.1016/s1051-0443(03)70182-1] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
248 Okino Y, Kiyosue H, Matsumoto S, Takaji R, Yamada Y, Mori H. Hepatocellular carcinoma: prediction of blood supply from right inferior phrenic artery by multiphasic CT. J Comput Assist Tomogr. 2003;27:341-346. [PMID: 12794596 DOI: 10.1097/00004728-200305000-00007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
249 Raoul J, Bretagne J, Bourguet P, Duvauferrier R. Limitations of Hyperselective Intraarterial Injections for the Treatment of Hepatocellular Carcinoma: . Investigative Radiology 1996;31:305-7. [DOI: 10.1097/00004424-199605000-00011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
250 Inoue A, Ota S, Takaki K, Imai Y, Sato S, Watanabe S, Tomozawa Y, Iwai T, Murakami Y, Sonoda A, Nitta N, Murata K. Change in hepatic hemodynamics assessed by hepatic arterial blood pressure and computed tomography during hepatic angiography with the double balloon technique. Jpn J Radiol 2019;37:487-93. [DOI: 10.1007/s11604-019-00836-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
251 Kattipatanapong T, Nishiofuku H, Tanaka T, Sato T, Masada T, Tatsumoto S, Matsumoto T, Kichikawa K. Improved Local Tumor Control and Survival Rates by Obtaining a 3D-Safety Margin in Superselective Transarterial Chemoembolization for Small Hepatocellular Carcinoma. Cardiovasc Intervent Radiol 2020;43:423-33. [DOI: 10.1007/s00270-019-02365-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
252 Yu J, Kim KW, Park M, Yoon S. Bile Duct Injuries Leading to Portal Vein Obliteration after Transcatheter Arterial Chemoembolization in the Liver: CT Findings and Initial Observations. Radiology 2001;221:429-36. [DOI: 10.1148/radiol.2212010339] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]